Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab

Nature Clinical Practice. Oncology
Stephanie HaleneNancy Berliner

Abstract

A 73-year-old woman presented with acute lower back pain, fever, chills and arthralgias. She had previously had a positive protein derivative test with a negative chest X-ray; her medical history was also remarkable for a mitral valve prolapse. Initial symptoms resolved spontaneously without therapy, but fever recurred with associated arthralgias, myalgias, diffuse and worsening lymphadenopathy, splenomegaly, and bilateral pulmonary infiltrates. Physical examination, blood and urine cultures, MRI of the spine, echocardiogram, extensive serologies, serum and urine protein electrophoresis, immunofixation electrophoresis, bone-marrow aspiration and biopsy with flow cytometry, cytogenetics, and gene rearrangement studies, CT scan of the chest, abdomen and pelvis, whole-body PET, and lymph-node biopsy for histological examination, immunohistochemistry, and gene rearrangement studies. Angioimmunoblastic T-cell lymphoma. Steroids (prednisone, methylprednisolone), levofloxacin, isoniazid with pyridoxine, ciclosporin A, methotrexate, alemtuzumab, broad-spectrum antibiotics, Pneumocystis carinii prophylaxis, vancomycin, and clindamycin.

References

Feb 6, 1988·Lancet·A G StansfeldO Mioduszewska
Jun 1, 1974·Lancet·G FrizzeraH Rappaport
Aug 27, 2002·Advances in Anatomic Pathology·Judith A Ferry
Jun 5, 2003·British Journal of Haematology·Ahmet DoganChara Kyriakou
Jun 7, 2003·Drugs·James E Frampton, Antona J Wagstaff
Mar 11, 2005·Expert Review of Anticancer Therapy·Farhad Ravandi, Susan O'Brien

❮ Previous
Next ❯

Citations

Sep 4, 2012·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Jew Win KuanAnselm Ting Su
Aug 28, 2009·The New England Journal of Medicine·Jeremy S AbramsonJudith A Ferry
Dec 9, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kieron DunleavySusan E Bates
Jan 29, 2009·Acta Oncologica·Fadi BraitehPeter McLaughlin
Jun 25, 2010·Leukemia & Lymphoma·Jennifer E Amengual, Bruce G Raphael
Apr 25, 2007·Leukemia & Lymphoma·Barbara Pro, Peter McLaughlin
Mar 24, 2007·European Journal of Haematology·José RodríguezUNKNOWN Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea
Apr 13, 2011·British Journal of Haematology·Claire E DeardenUNKNOWN British Committee for Standards in Haematology
Mar 23, 2011·Expert Review of Anticancer Therapy·Rebecca A Howman, H Miles Prince
Sep 24, 2011·Expert Review of Hematology·Fernando RoncolatoPier Paolo Piccaluga
Jul 2, 2014·Proceedings·Michael S HumeniukDavid J Inwards

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.